Navigation Links
Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
Date:5/29/2013

Ponte Vedra Beach, FL (PRWEB) May 29, 2013

This week’s top news story on HealthEconomics.Com covered newly released survey results on Payer Strategies for Emerging Markets, conducted by Hanson Wade, based on interviews with Pharma/Biotech/Medical Device companies, Consulting companies, Academia, Regulators, and Providers. There was universal consensus among the respondents that, by 2018, more than one-third of pharmaceutical company revenues will come from emerging markets, including Brazil, Russia, Asia/Pac, Africa, among others. The greatest barrier to pharma growth in emerging markets was weak industry-payer partnerships (33% of respondents), followed by lack of out-of-pocket payer engagement (22%) and competition from generics (22%). Diabetes was thought to be the biggest potential therapeutic area, while Saudia Arabia followed by Nigeria were two countries of focus after BRIC TM (Brazil, Russia, India, China, Turkey, and Mexico) emerging markets. This story was sourced from Hanson Wade Limited.

The second most read story on HealthEconomics.Com was derived from an abstract by Dr. Gary Lyman, of Duke University and the Duke Cancer Institute in Durham, North Carolina, published in The Oncologist journal on May 22, 2013 discussing comparative effectiveness research (CER) in oncology. Oncology is a therapeutic area that is uniquely positioned to utilize CER to inform appropriate and optimal patient care, particularly among high-cost interventions. The author posits that the development and evaluation of genomic and other personalized medicine approaches poses significant challenges for CER in oncology. Lyman has written on this subject in other journals, including the Journal of Clinical Oncology.

Another popular news item on HealthEconomics.Com covered the latest addition to the HE-Artist series with a profile of Sean Sullivan, PhD, Professor and Associate Dean for Research at the University of Washington School of Pharmacy who is also a drummer and plays in a band of health economists called The Monte Carlos. Dr. Sullivan’s passion for drumming, coupled with his many contributions to the field of health economics and health policy, are featured in HE-Artists on HealthEconomics.Com.

About HealthEconomics.Com (http://www.healtheconomics.com):
A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/TopNews/prweb10778875.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
2. MSU invention could help pharmaceutical industry save money
3. Nobel laureate to keynote international pharmaceutical conference at URI
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
6. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. Medical care presents update on pharmaceutical health services research
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... ... ChenMed , a leading provider of value-based care for seniors, today announced ... Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine at the ... for the UVA Health System, brings 30 years of highly relevant experience to his ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced ... its existing adherence automation lines. The ATP® Mini and InspectRx® Mini ... TCG’s standard products, but at a size and price point that can help ...
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch ... of - living - adjustment (COLA) is a bad deal for older and disabled ... price index (CPI) would grow even more slowly than the conventional one that is ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... International plc (NASDAQ: ENDP ) will announce its second-quarter ... senior management team will host a conference call and webcast before ... The dial-in number to access the call is U.S./ ... is 45397076. Please dial in 10 minutes prior to the scheduled ... of the call will be available from August 8, 2017 at ...
(Date:7/12/2017)... 2017 CarpalAID is a revolutionary new product that relieves ... Carpal tunnel syndrome affects more than 8 million people a ... of men. The common methods of treating CTS are painful surgery, ... braces or gloves. ... CarpalAID is a clear patch worn on the palm ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology: